1-1 of 1
Gallia G. Levy
Close
Sort by
Journal Articles

A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers

Clinical Trials & Observations
Genmin Lu, Pamela B. Conley, Janet M. Leeds, Mark J. Karbarz, Gallia G. Levy, Vandana S. Mathur, Janice Castillo, Mark Crowther, John T. Curnutte
Journal: Blood Advances
Blood Adv (2020) 4 (4): 728–739.
https://doi.org/10.1182/bloodadvances.2019000885
Published: 2020
Includes: Supplemental data